published meta-analysis   sensitivity analysis   studies

chloroquine in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsChen, ChiCTR2000030054 - Chloroquine, 2020 0.66 [0.01; 35.52] NCT04342650, 2020 0.95 [0.02; 48.42] 0.79[0.05; 13.03]Chen, ChiCTR2000030054 - Chloroquine, 2020, NCT04342650, 202020%182lownot evaluable adverse eventsdetailed resultsChen, ChiCTR2000030054 - Chloroquine, 2020 1.92 [0.31; 12.05] 1.92[0.31; 12.05]Chen, ChiCTR2000030054 - Chloroquine, 202010%30NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-04-28 22:32 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 656 - roots T: 290